New dengue drug shows promise in clinical trial
Disease control
Recruiting now
This study tests an experimental drug called CP-COV03 in adults with dengue fever. The goal is to see if it safely reduces the virus and speeds up symptom recovery. About 210 participants will receive either the drug or a placebo. The trial is currently recruiting.
Phase: PHASE2, PHASE3 • Sponsor: Hyundai Bioscience Co., Ltd. • Aim: Disease control
Last updated May 14, 2026 12:04 UTC